| Particulars |
| Company Name |
Glaxosmithkline Pharmaceuticals Ltd |
| Face Value |
10 |
| BSE Code |
500660 |
| Year End |
202503 |
| Full Year |
| Equity (Rs in Cr.) |
169.41 |
| B.V. Rs |
115.10 |
| Sales Rs in Cr. |
3,723.49 |
| NP Rs in Cr. |
865.43 |
| NP Var% |
33.00 |
| Div% |
540.00 |
| CPS Rs |
55.00 |
| EPS Rs |
51.10 |
| Traded Value(Rs in Lakhs) |
227.99 |
| 52 Week High |
3,516.00 |
| 52 Week Low |
1,924.00 |
| Price BSE |
3,458.00 |
| Price NSE |
3,440.00 |
| Market Capital(Rs in Cr.) |
58,575.52 |
| P/C Ratio |
62.80 |
| P/E Ratio |
67.70 |
| Price Vs.BV |
30.04 |
| Latest Quarter |
| Year End |
202503 |
| Sales Rs in Cr. |
966.08 |
| NP Rs in Cr. |
260.14 |
| NP Var % |
36.00 |
| Trailing Twelve Months |
| Year End |
202503 |
| Sales |
3,526.90 |
| OPM |
-5.85 |
| NP |
795.84 |
| NP Var% |
32.88 |
| EPS |
51.09 |
| PE |
67.68 |
|